tradingkey.logo

SWK Holdings Corp

SWKH
View Detailed Chart

15.010USD

+0.100+0.67%
Close 07/11, 16:00ETQuotes delayed by 15 min
183.46MMarket Cap
10.04P/E TTM

SWK Holdings Corp

15.010

+0.100+0.67%
Intraday
1m
30m
1h
D
W
M
D

Today

+0.67%

5 Days

-0.33%

1 Month

+2.32%

6 Months

+20.35%

Year to Date

+19.51%

1 Year

+11.50%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 1 analysts
BUY
Current Rating
18.000
Target Price
20.72%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

12
Total
4
Median
4
Average
Company name
Ratings
Analysts
SWK Holdings Corp
SWKH
1
AerCap Holdings NV
AER
10
Runway Growth Finance Corp
RWAY
10
Air Lease Corp
AL
7
NewtekOne Inc
NEWT
6
Lufax Holding Ltd
LU
5
1
2
3

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

1m
15m
30m
1h
D
W
M
1m
15m
30m
D
Neutral
Sell(4)
Neutral(3)
Buy(6)
Indicators
Sell(2)
Neutral(3)
Buy(2)
Indicators
Value
Direction
MACD(12,26,9)
-0.017
Neutral
RSI(14)
56.181
Neutral
STOCH(KDJ)(9,3,3)
57.918
Sell
ATR(14)
0.313
Low Volatility
CCI(14)
39.166
Neutral
Williams %R
33.981
Buy
TRIX(12,20)
0.249
Sell
StochRSI(14)
24.640
Buy
Moving Average
Sell(2)
Neutral(0)
Buy(4)
Indicators
Value
Direction
MA5
15.088
Sell
MA10
15.059
Sell
MA20
14.821
Buy
MA50
14.326
Buy
MA100
13.986
Buy
MA200
13.502
Buy

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

SWK Holdings Corporation is a life science focused specialty finance company. The Company’s segments include Finance Receivables and Pharmaceutical Development. Its Finance Receivables segment is a healthcare capital provider, which offers customized financing solutions to a range of life science companies, institutions, and inventors. This segment is primarily focused on monetizing cash flow streams derived from commercial-stage products and related intellectual property through royalty purchases and financings, as well as through the creation of synthetic revenue interests in commercialized products. Its Pharmaceutical Development segment operates through its subsidiary Enteris BioPharma, Inc. (Enteris). Enteris is a clinical development and manufacturing organization providing development services to pharmaceutical partners as well as innovative formulation solutions built around its oral drug delivery technologies.
Ticker SymbolSWKH
CompanySWK Holdings Corp
CEOMr. Joe D. Staggs
Websitehttps://www.swkhold.com/
KeyAI